In Young Hwang

Hwang In Young

Appointment(s)
  • Senior Research Fellow, Department of Biochemistry
Academic Qualifications
  • Bachelor of Science (Hons), University of Auckland¬†
  • PhD, University of Auckland |
Research Interest(s)
  • Synthetic Biology, Microbiome Engineering, Gut Microbiota, Mammalian Cell Engineering
Recent Publications
  • 1. Hwang IY, Koh E, Wong CK, March JC, Bentley WE, Lee YS, Chang M. 2017 Apr. Engineered probiotic Escherichia coli eliminate and prevent Pseudomonas aeruginosa gut infection in animal models. Nature Communications. 8:15028. doi :10.1038/NCOMMS15028.
  • 2. Hwang IY, Koh E, Kim HR, Chang MW. 2016 Jul. Reprogrammable microbial cell-based therapeutics against antibiotic-resistant bacteria. Drug Resistance Updates. 27:59-71. doi: 10.1016/j.drup.2016.06.002.
  • 3. Ho CL, Hwang IY, Loh, K, Chang MW. 2015 Jan. Matrix-immobilized yeast for large-scale production of recombinant human lactoferrin. MedChemComm. 6(3):486-491. doi: 10.1039/c4md00537f.
  • 4. Hwang IY, Tan MH, Koh E, Ho CL, Poh CL, Chang MW. 2014 Apr. Reprogramming microbes to be a pathogen-seeking killer. ACS Synthetic Biology. 3(4):228-237. doi: 10.1021/sb400077j.
  • 5. Wong CK, Tan MH, Rasouliha BH, Hwang IY, Ling H, Poh CL, Chang MW. 2014 Jan. Therapeutic microbes for infectious disease. Methods in Molecular Biology. 1151:117-33. doi: 10.1007/978-1-4939-0554-6_9.